Klebsiella pneumoniae (Kp) is a gram-negative bacterium belonging to the family Enterobacteriaceae, which most often causes multidrug resistance (MDR) community-acquired pneumonia (CAP). Over the past few years, there has been an increase in infections caused by resistant Kp, causing severe consequences, especially in the hospital setting, such as more extended hospital stays, lack of treatment options, and increased morbidity and mortality rates. 2 The incidence of CAP caused by Kp from eight countries in Asia demonstrated a mortality rate of 28 days for CAP and nosocomial pneumonia, accounting for 27.9% and 36.9%, respectively. Klebsiella pneumoniae in CAP has the highest proportion of hypervirulent strains (HvKp strains). 3 In vitro and in vivo studies involving different antibiotics, herbal ingredients, or combinations of antibiotics and herbal ingredients have been conducted to mitigate the MDR nature of Kp. Extracts of Cinnamomum Cassia with anti-inflammatory activity and used in treating wounds have also been investigated. 4 Studies on Cinnamomum burmannii Bark oil (CbBO) showed that it has antimicrobial properties and could benefit health when used as an alternative antibacterial agent in medical applications and antibacterial supplements in health products. Its use could lead to reduced drug costs, with no acute or chronic toxicity, mutagenicity or genotoxicity, and no carcinogenicity detected in mammalian studies. 4,5 Cinnamomum burmannii Bark oil has the highest concentrations of Cinnamaldehyde (65-80%) and Eugenol (5-10%) compared to other herbal essential oils, which exhibits antibacterial and anti-inflammatory properties. 6,7 Eugenol causes disruption of the cytoplasmic membrane, increases nonspecific permeability, causes ion leakage, and excessive loss of other cellular components, including intracellular proteins, leading to cell death. 8 Cinnamaldehyde inhibits the ATPase enzyme and damages